[ad_1] Ad hoc announcement pursuant to Art. 53 LR ‘Pure-play’ innovative medicines strategy focused on four therapeutic areas and five technology platforms, which offer potential for consistent growth Mid-term sales…
Tag: Ad Hoc
Novartis executes Sandoz Spin-off, completing strategic transformation into a leading, focused innovative medicines company
[ad_1] Ad hoc announcement pursuant to Art. 53 LR Novartis executes separation of the Sandoz business to create an independent company by way of a 100% Spin-off Shares of Sandoz…